2024-03-28T19:26:14Zhttp://repisalud.isciii.es/oai/requestoai:repisalud.isciii.es:20.500.12105/138162022-11-03T14:37:20Zcom_20.500.12105_15322com_20.500.12105_2051com_20.500.12105_2174com_20.500.12105_2173col_20.500.12105_16938col_20.500.12105_2175
Repisalud
author
Cerezo-Wallis, Daniela
author
Mucientes, Cynthia
author
Calvo, Tonantzin G
author
Cañón, Estela
author
Alonso-Curbelo, Direna
author
Ibarz, Nuria
author
Muñoz, Javier
author
Rodriguez-Peralto, José L
author
Ortiz-Romero, Pablo
author
Soengas, MS
author
Ortega Jimenez, Sagrario
author
Olmeda, David
funder
Asociación Española Contra el Cáncer
funder
Fundación La Caixa
funder
Melanoma Research Alliance
funder
Instituto de Salud Carlos III
funder
Fundación BBVA
funder
Ministerio de Economía, Industria y Competitividad (España)
2022-03-24T13:45:45Z
2022-03-24T13:45:45Z
2021-12-07
EMBO Mol Med . 2021;13(12):e12924
http://hdl.handle.net/20.500.12105/13816
34762341
10.15252/emmm.202012924
1757-4684
EMBO molecular medicine
Long-range communication between tumor cells and the lymphatic vasculature defines competency for metastasis in different cancer types, particularly in melanoma. Nevertheless, the discovery of selective blockers of lymphovascular niches has been compromised by the paucity of experimental systems for whole-body analyses of tumor progression. Here, we exploit immunocompetent and immunodeficient mouse models for live imaging of Vegfr3-driven neolymphangiogenesis, as a versatile platform for drug screening in vivo. Spatiotemporal analyses of autochthonous melanomas and patient-derived xenografts identified double-stranded RNA mimics (dsRNA nanoplexes) as potent inhibitors of neolymphangiogenesis, metastasis, and post-surgical disease relapse. Mechanistically, dsRNA nanoplexes were found to exert a rapid dual action in tumor cells and in their associated lymphatic vasculature, involving the transcriptional repression of the lymphatic drivers Midkine and Vegfr3, respectively. This suppressive function was mediated by a cell-autonomous type I interferon signaling and was not shared by FDA-approved antimelanoma treatments. These results reveal an alternative strategy for targeting the tumor cell-lymphatic crosstalk and underscore the power of Vegfr3-lymphoreporters for pharmacological testing in otherwise aggressive cancers.
eng
Live imaging of neolymphangiogenesis identifies acute antimetastatic roles of dsRNA mimics.
journal article
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
URL
https://repisalud.isciii.es/bitstream/20.500.12105/13816/1/Liveimagingofneolymphangiogenesis_2021.pdf
File
MD5
6eeca57499d2b8593439acc6668b550c
3588497
application/pdf
Liveimagingofneolymphangiogenesis_2021.pdf
URL
https://repisalud.isciii.es/bitstream/20.500.12105/13816/2/emmm202012924-sup-0001-evfigs.pdf
File
MD5
0151301c47f7aa0f03979d248a15fd32
2770056
application/pdf
emmm202012924-sup-0001-evfigs.pdf
URL
https://repisalud.isciii.es/bitstream/20.500.12105/13816/3/Copia%20de%20emmm202012924-sup-0002-datasetev1.xlsx
File
MD5
e3f7f4f9ce2b9fee1e3815db756ee558
12899
application/vnd.openxmlformats-officedocument.spreadsheetml.sheet
Copia de emmm202012924-sup-0002-datasetev1.xlsx
URL
https://repisalud.isciii.es/bitstream/20.500.12105/13816/4/Copia%20de%20emmm202012924-sup-0003-datasetev2.xlsx
File
MD5
33559be8425361045f1380f04aed1b39
12908
application/vnd.openxmlformats-officedocument.spreadsheetml.sheet
Copia de emmm202012924-sup-0003-datasetev2.xlsx
URL
https://repisalud.isciii.es/bitstream/20.500.12105/13816/5/Copia%20de%20emmm202012924-sup-0004-datasetev3.xlsx
File
MD5
c8fd3de84bbf540322126b2b2b511202
12194
application/vnd.openxmlformats-officedocument.spreadsheetml.sheet
Copia de emmm202012924-sup-0004-datasetev3.xlsx
URL
https://repisalud.isciii.es/bitstream/20.500.12105/13816/6/Copia%20de%20emmm202012924-sup-0005-datasetev4.xlsx
File
MD5
6a1953f10cb9b800c75ea6f733a0b561
11457
application/vnd.openxmlformats-officedocument.spreadsheetml.sheet
Copia de emmm202012924-sup-0005-datasetev4.xlsx
URL
https://repisalud.isciii.es/bitstream/20.500.12105/13816/7/Copia%20de%20emmm202012924-sup-0006-datasetev5.xlsx
File
MD5
d99451d17f453317ae6bd1107b2d2b84
34900
application/vnd.openxmlformats-officedocument.spreadsheetml.sheet
Copia de emmm202012924-sup-0006-datasetev5.xlsx
URL
https://repisalud.isciii.es/bitstream/20.500.12105/13816/8/Copia%20de%20emmm202012924-sup-0007-datasetev6.xlsx
File
MD5
78e6ab5e1b6034a07a2c1d2ce9beca9a
34897
application/vnd.openxmlformats-officedocument.spreadsheetml.sheet
Copia de emmm202012924-sup-0007-datasetev6.xlsx
URL
https://repisalud.isciii.es/bitstream/20.500.12105/13816/9/Movie%20EV1%20legend.docx
File
MD5
d7542fde53adc914ecb9976f9a5356c1
12057
application/vnd.openxmlformats-officedocument.wordprocessingml.document
Movie EV1 legend.docx
URL
https://repisalud.isciii.es/bitstream/20.500.12105/13816/12/Liveimagingofneolymphangiogenesis_2021.pdf.txt
File
MD5
95a267b2cf3ea83fb6093bee0d2a9682
92740
text/plain
Liveimagingofneolymphangiogenesis_2021.pdf.txt
URL
https://repisalud.isciii.es/bitstream/20.500.12105/13816/14/emmm202012924-sup-0001-evfigs.pdf.txt
File
MD5
0790a8218c7c709bd240b3a1e4a1ad75
7371
text/plain
emmm202012924-sup-0001-evfigs.pdf.txt